Forecast the Global Lung Cancer Therapeutics Market to contribute around $11.19 billion during the period 2017-2020
ResearchMoz presents professional and in-depth study of "Global Lung Cancer Therapeutics Market 2016-2020". Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly. Technavios analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also consider...